These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 31745346)
1. Human and translational immunology in the third millennium: progress, challenges and opportunities. Galani IE; Klechevsky E; Andreakos E Nat Immunol; 2019 Dec; 20(12):1568-1573. PubMed ID: 31745346 [TBL] [Abstract][Full Text] [Related]
2. DNA vaccines 2014 meeting: Highlights and overview. Ugen KE; Weiner DB Hum Vaccin Immunother; 2015; 11(8):1887-8. PubMed ID: 26158530 [No Abstract] [Full Text] [Related]
3. [New dimensions for dendritic cells]. Hänninen A Duodecim; 2014; 130(9):883-91. PubMed ID: 24881140 [TBL] [Abstract][Full Text] [Related]
4. [Immunology. Realizable discoveries]. Kabelitz D Dtsch Med Wochenschr; 1999 Dec; 124(51-52):1570-2. PubMed ID: 10664659 [No Abstract] [Full Text] [Related]
5. The science and medicine of human immunology. Pulendran B; Davis MM Science; 2020 Sep; 369(6511):. PubMed ID: 32973003 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: a 10-year anniversary issue. Gregg M Immunotherapy; 2019 Jan; 11(1):1-2. PubMed ID: 30702007 [No Abstract] [Full Text] [Related]
7. Letter from the editor. Ellis R; Riedmann EM Hum Vaccin Immunother; 2014; 10(1):1-2. PubMed ID: 24832715 [No Abstract] [Full Text] [Related]
8. High-affinity anti-glycan antibodies: challenges and strategies. Polonskaya Z; Savage PB; Finn MG; Teyton L Curr Opin Immunol; 2019 Aug; 59():65-71. PubMed ID: 31029911 [TBL] [Abstract][Full Text] [Related]
9. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Klinman DM; Klaschik S; Sato T; Tross D Adv Drug Deliv Rev; 2009 Mar; 61(3):248-55. PubMed ID: 19272313 [TBL] [Abstract][Full Text] [Related]
10. Letter from the Editor. Ellis R; Weiss A Hum Vaccin Immunother; 2015; 11(6):1297. PubMed ID: 26086583 [No Abstract] [Full Text] [Related]
11. Progress towards achieving new vaccine and vaccination goals. Ada G Intern Med J; 2003 Jul; 33(7):297-304. PubMed ID: 12823675 [TBL] [Abstract][Full Text] [Related]
12. Vaccination and herd immunity: what more do we know? Rashid H; Khandaker G; Booy R Curr Opin Infect Dis; 2012 Jun; 25(3):243-9. PubMed ID: 22561998 [TBL] [Abstract][Full Text] [Related]
14. -ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science? Ballow M J Allergy Clin Immunol; 2005 Oct; 116(4):738-43. PubMed ID: 16210044 [No Abstract] [Full Text] [Related]
15. Toward the development of vectored vaccines in compliance with evolutionary medicine. Tang DC; Van Kampen KR Expert Rev Vaccines; 2008 May; 7(4):399-402. PubMed ID: 18444885 [No Abstract] [Full Text] [Related]
16. [Status and prospects of immunologic disease prevention]. Morunova AA Pediatriia; 1989; (7):5-7. PubMed ID: 2780160 [No Abstract] [Full Text] [Related]
17. [ABOUT SIGNIFICANT ISSUES IN EFFICIENCY OF THE EPIDEMIOLOGICAL SURVEILLANCE OF INFECTIOUS DISEASES IN RUSSIAN FEDERATION]. Shkarin VV; Kovalishena OV Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):121-6. PubMed ID: 26951001 [No Abstract] [Full Text] [Related]
18. Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents. Srivastava PK; Amato RJ Vaccine; 2001 Mar; 19(17-19):2590-7. PubMed ID: 11257397 [TBL] [Abstract][Full Text] [Related]